Maywufa

Maywufa is a prominent Taiwanese healthcare and consumer products company that serves as the flagship of the Maywufa Bio-Tech Group. Established in 1976, the company initially specialized in hair care products, where it maintains a leading market share in Taiwan, before expanding into pharmaceutical distribution and biotechnology. Through its subsidiaries like PhytoHealth Corp, the group develops innovative botanical drugs, including the first botanical drug approved by the Taiwan FDA for cancer-related fatigue. Maywufa is listed on the Taiwan Stock Exchange and operates a comprehensive business model spanning R&D, manufacturing, and multi-channel distribution of medical and beauty products. The company's pharmaceutical division distributes a wide range of products, including cardiovascular, metabolic, and central nervous system medications. With a strong focus on Beauty and Health, Maywufa continues to integrate traditional consumer goods with advanced life science research.